Literature DB >> 19893461

Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.

Akihiro Tamiya, Masahiro Endo, Takehito Shukuya, Satoshi Igawa, Asuka Tsuya, Yukiko Nakamura, Haruyasu Murakami, Toshiaki Takahashi, Narikazu Boku, Nobuyuki Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19893461     DOI： 10.1097/MPA.0b013e3181ad97cf

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  4 in total

1.  Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications.

Authors:  Ibrahim Halil Sahin; Alexander I Geyer; Daniel W Kelly; Eileen Mary O'Reilly
Journal:  Clin Colorectal Cancer       Date:  2015-08-22       Impact factor: 4.481

2.  A case of late-onset gemcitabine lung toxicity.

Authors:  Amanda M Sherrod; Adam Brufsky; Shannon Puhalla
Journal:  Clin Med Insights Oncol       Date:  2011-05-29

3.  The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer.

Authors:  Meiko Nishimura; Masanori Toyoda; Kei Takenaka; Yoshinori Imamura; Naoko Chayahara; Naomi Kiyota; Toru Mukohara; Takeshi Kotake; Akihito Tsuji; Kosuke Saito; Yoshiro Saito; Hironobu Minami
Journal:  Cancer Chemother Pharmacol       Date:  2016-04-21       Impact factor: 3.333

4.  Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy.

Authors:  Naoto Iwai; Takashi Okuda; Ryo Sawada; Tomoya Ohara; Chie Hattori; Masashi Taniguchi; Hiroaki Sakai; Kohei Oka; Tasuku Hara; Toshifumi Tsuji; Toshiyuki Komaki; Junichi Sakagami; Keizo Kagawa; Osamu Dohi; Hiroaki Yasuda; Yoshito Itoh
Journal:  Case Rep Gastroenterol       Date:  2022-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.